PL1865924T3 - Sposób leczenia chorób gruczołu krokowego oparty na miejscowym dostarczaniu substancji czynnych - Google Patents
Sposób leczenia chorób gruczołu krokowego oparty na miejscowym dostarczaniu substancji czynnychInfo
- Publication number
- PL1865924T3 PL1865924T3 PL06724133T PL06724133T PL1865924T3 PL 1865924 T3 PL1865924 T3 PL 1865924T3 PL 06724133 T PL06724133 T PL 06724133T PL 06724133 T PL06724133 T PL 06724133T PL 1865924 T3 PL1865924 T3 PL 1865924T3
- Authority
- PL
- Poland
- Prior art keywords
- active substances
- local delivery
- treating prostate
- diseases based
- prostate diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200500452 | 2005-03-31 | ||
PCT/EP2006/003194 WO2006103112A2 (en) | 2005-03-31 | 2006-03-31 | Method for treating prostate diseases based on local delivery of active substances |
EP06724133.1A EP1865924B1 (en) | 2005-03-31 | 2006-03-31 | Method for treating prostate diseases based on local delivery of active substances |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1865924T3 true PL1865924T3 (pl) | 2016-06-30 |
Family
ID=35044589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06724133T PL1865924T3 (pl) | 2005-03-31 | 2006-03-31 | Sposób leczenia chorób gruczołu krokowego oparty na miejscowym dostarczaniu substancji czynnych |
Country Status (17)
Country | Link |
---|---|
US (1) | US8936809B2 (pl) |
EP (1) | EP1865924B1 (pl) |
JP (2) | JP5635231B2 (pl) |
KR (2) | KR20140014294A (pl) |
CN (1) | CN101160116B (pl) |
AU (1) | AU2006228675B2 (pl) |
CA (1) | CA2602776C (pl) |
DK (1) | DK1865924T3 (pl) |
ES (1) | ES2557988T3 (pl) |
HU (1) | HUE026158T2 (pl) |
IL (1) | IL185690A0 (pl) |
MX (1) | MX2007011908A (pl) |
NO (1) | NO338679B1 (pl) |
PL (1) | PL1865924T3 (pl) |
RU (1) | RU2404747C2 (pl) |
WO (1) | WO2006103112A2 (pl) |
ZA (1) | ZA200708066B (pl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5635231B2 (ja) * | 2005-03-31 | 2014-12-03 | リッズ エービーLidds Ab | 活性物質の局所送達に基づく前立腺疾患の治療方法 |
ES2545962T3 (es) * | 2008-11-27 | 2015-09-17 | Lidds Ab | Uso de carboximetilcelulosa para controlar la capacidad de eyección y el tiempo de solidificación de composiciones que comprenden una o más cerámicas biorreabsorbibles |
GB2513675A (en) * | 2011-04-05 | 2014-11-05 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
RU2519407C2 (ru) * | 2011-09-21 | 2014-06-10 | Виктор Павлович Горелов | Способ трансуретральной резекции предстательной железы, предшествующий брахитерапии рака простаты |
GB201318862D0 (en) * | 2013-10-25 | 2013-12-11 | Glaxosmithkline Biolog Sa | Calcium fluoride compositions |
GB201318858D0 (en) * | 2013-10-25 | 2013-12-11 | Glaxosmithkline Biolog Sa | Calcium fluoride compositions |
JP6691715B2 (ja) | 2014-08-19 | 2020-05-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 局所的薬物送達のためのインプラント及びその使用 |
WO2016197100A1 (en) | 2015-06-04 | 2016-12-08 | Crititech, Inc. | Nozzle assembly and methods for use |
KR102490665B1 (ko) | 2016-04-04 | 2023-01-27 | 크리티테크, 인크. | 고형 종양의 치료 방법 |
WO2018227037A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
WO2018231908A1 (en) | 2017-06-14 | 2018-12-20 | Crititech, Inc. | Methods for treating lung disorders |
BR112020005814A2 (pt) | 2017-10-03 | 2020-09-24 | Crititech, Inc. | administração local de partículas antineoplásicas em combinação com administração sistêmica de agentes imunoterapêuticos para o tratamento de câncer |
US11911499B2 (en) | 2019-11-07 | 2024-02-27 | Resurge Therapeutics, Inc. | System and method for prostate treatment |
US11344526B2 (en) * | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11338119B2 (en) * | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11173291B2 (en) * | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US20240100010A9 (en) * | 2020-03-20 | 2024-03-28 | The Regents Of The University Of California | Implantable Drug Delivery Devices For Localized Drug Delivery |
US11602516B1 (en) | 2022-01-29 | 2023-03-14 | Resurge Therapeutics Inc. | Treating benign prostatic hyperplasia |
WO2023147080A1 (en) * | 2022-01-29 | 2023-08-03 | Resurge Therapeutics, Inc. | Benign prostatic hyperplasia treatment system |
US11957654B2 (en) | 2022-01-29 | 2024-04-16 | Resurge Therapeutics, Inc. | Treating benign prostatic hyperplasia |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474813A (en) * | 1980-10-24 | 1984-10-02 | Schering Corporation | Pharmaceutical preparations comprising flutamide |
US5614206A (en) * | 1995-03-07 | 1997-03-25 | Wright Medical Technology, Inc. | Controlled dissolution pellet containing calcium sulfate |
US5795330A (en) | 1996-10-10 | 1998-08-18 | Etex Corporation | Mixing device |
CA2268156C (en) * | 1996-10-16 | 2007-05-29 | Etex Corporation | Bioceramic compositions |
US6391336B1 (en) * | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
US5972384A (en) * | 1997-10-01 | 1999-10-26 | University Of Maryland, Baltimore | Use of biologically active glass as a drug delivery system |
AU6318900A (en) * | 1999-08-05 | 2001-03-05 | Takeda Chemical Industries Ltd. | Pastes with the sustained release of osteogenesis promoter |
US6497901B1 (en) * | 2000-11-02 | 2002-12-24 | Royer Biomedical, Inc. | Resorbable matrices for delivery of bioactive compounds |
US6645974B2 (en) * | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
US20030147936A1 (en) * | 2002-02-07 | 2003-08-07 | Velayudhan Sahadevan | Prostatic hormonal implants treatment of prostate cancer |
EP1660473A2 (en) * | 2003-03-24 | 2006-05-31 | Luitpold Pharmaceuticals, Inc. | Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
GB0307082D0 (en) * | 2003-03-27 | 2003-04-30 | Gyne Ideas Ltd | Drug delivery device and method |
KR100849911B1 (ko) * | 2003-04-03 | 2008-08-04 | 제시 엘. 에스. 에이유 | 종양-표적화 약물-로딩된 입자 |
US20040224000A1 (en) * | 2003-05-05 | 2004-11-11 | Romano Deghenghi | Implants for non-radioactive brachytherapy of hormonal-insensitive cancers |
EP1680089B1 (en) * | 2003-10-22 | 2013-09-11 | Lidds AB | Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
JP5635231B2 (ja) * | 2005-03-31 | 2014-12-03 | リッズ エービーLidds Ab | 活性物質の局所送達に基づく前立腺疾患の治療方法 |
-
2006
- 2006-03-31 JP JP2008503447A patent/JP5635231B2/ja active Active
- 2006-03-31 PL PL06724133T patent/PL1865924T3/pl unknown
- 2006-03-31 US US11/910,162 patent/US8936809B2/en active Active
- 2006-03-31 EP EP06724133.1A patent/EP1865924B1/en active Active
- 2006-03-31 DK DK06724133.1T patent/DK1865924T3/en active
- 2006-03-31 CA CA2602776A patent/CA2602776C/en active Active
- 2006-03-31 RU RU2007140243/14A patent/RU2404747C2/ru active
- 2006-03-31 AU AU2006228675A patent/AU2006228675B2/en active Active
- 2006-03-31 KR KR1020137034233A patent/KR20140014294A/ko not_active Application Discontinuation
- 2006-03-31 KR KR1020077022037A patent/KR101380402B1/ko active IP Right Grant
- 2006-03-31 CN CN2006800100200A patent/CN101160116B/zh active Active
- 2006-03-31 WO PCT/EP2006/003194 patent/WO2006103112A2/en active Application Filing
- 2006-03-31 MX MX2007011908A patent/MX2007011908A/es active IP Right Grant
- 2006-03-31 ES ES06724133.1T patent/ES2557988T3/es active Active
- 2006-03-31 HU HUE06724133A patent/HUE026158T2/en unknown
-
2007
- 2007-09-03 IL IL185690A patent/IL185690A0/en active IP Right Grant
- 2007-09-19 ZA ZA2007/08066A patent/ZA200708066B/en unknown
- 2007-10-30 NO NO20075490A patent/NO338679B1/no unknown
-
2012
- 2012-11-27 JP JP2012258603A patent/JP2013067639A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP5635231B2 (ja) | 2014-12-03 |
EP1865924B1 (en) | 2015-12-09 |
KR101380402B1 (ko) | 2014-04-02 |
KR20140014294A (ko) | 2014-02-05 |
CN101160116A (zh) | 2008-04-09 |
ZA200708066B (en) | 2016-07-27 |
NO20075490L (no) | 2008-01-02 |
RU2404747C2 (ru) | 2010-11-27 |
JP2013067639A (ja) | 2013-04-18 |
KR20080002776A (ko) | 2008-01-04 |
HUE026158T2 (en) | 2016-05-30 |
RU2007140243A (ru) | 2009-05-10 |
CN101160116B (zh) | 2011-12-07 |
WO2006103112A3 (en) | 2006-12-21 |
US8936809B2 (en) | 2015-01-20 |
DK1865924T3 (en) | 2016-02-29 |
EP1865924A2 (en) | 2007-12-19 |
WO2006103112A2 (en) | 2006-10-05 |
CA2602776C (en) | 2013-10-22 |
CA2602776A1 (en) | 2006-10-05 |
AU2006228675A1 (en) | 2006-10-05 |
AU2006228675B2 (en) | 2012-05-17 |
MX2007011908A (es) | 2008-02-07 |
IL185690A0 (en) | 2008-01-06 |
NO338679B1 (no) | 2016-09-26 |
JP2008534546A (ja) | 2008-08-28 |
ES2557988T3 (es) | 2016-02-01 |
US20080286205A1 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL185690A0 (en) | Method for treating prostate diseases based on local delivery of active substances | |
IL291175A (en) | Compositions and methods for treating collagen-mediated diseases | |
IL253698A0 (en) | Neuroendocrine tumor treatment has used mTOR inhibitors | |
EP1907059A4 (en) | METHOD AND SYSTEM FOR PREDICTING DOSAGE ADMINISTRATION | |
HRP20150175T1 (en) | Means and methods for the treatment of tumorous diseases | |
EP1909904A4 (en) | METHODS AND APPARATUS FOR PLANNING AND ADMINISTERING RADIOTHERAPY TREATMENTS | |
IL182533A0 (en) | Prostate treatment stent | |
EP1819639A4 (en) | PROCESS FOR TREATING NEBULIZATION | |
EP1737482A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES | |
IL185256A0 (en) | Method and composition for treating peripheral vascular diseases | |
ZA200802064B (en) | Method for the treatment of acne | |
EP1846432A4 (en) | METHOD FOR MANUFACTURING TARGETED THERAPEUTIC AGENTS | |
ZA200808076B (en) | Methods for preventing and treating amyloidogenic diseases | |
ZA200806095B (en) | Means and methods for the treatment of tumorous diseases | |
EP2088862A4 (en) | METHOD OF TREATING CANCER | |
IL226362A0 (en) | compounds, and methods for treating cancer | |
EP1719514A4 (en) | MEDICAMENT FOR TREATING PAIN | |
ZA201001779B (en) | Compositions and methods for treating collagen-mediated diseases | |
EP1744802A4 (en) | K: P: BUTEYKO PROCEDURE FOR THE TREATMENT OF HYPOKARBIA | |
AU2005906580A0 (en) | Method of Treatment of Drug Dependencies | |
AU2006903728A0 (en) | Method for the treatment of cancer |